Zyprexa Lawsuit

Atypical Anti-Psychotic Drug Lawsuits

Zyprexa (Olanzapine®) Lawsuit

Zyprexa, like Risperdal and Seroquel, has been associated with serious
side effects in patients, especially those who have already been
diagnosed with diabetes.

Knowledge of the potential dangers of Zyprexa were discovered as a
result of a series of findings beginning in 2001 when the FDA was alerted
to 19 case reports of diabetes associated with the drug.

One of these cases resulted in a patient’s death due to necrotizing
pancreatitis, a very serious condition in which cells in the pancreas

An emergency report issued by the Japanese Health and Welfare Ministry
in April of 2002 concerning the side effects of Zyprexa noted that there
had been two deaths of patients who had diabetes prior to taking the
anti-psychotic medication. Read the rest of this entry »


Eli Lilly Settles $1.42 Billion in Zyprexa Lawsuit – Video

Drug manufacturer, Eli Lilly, settles $1.42 billion in Zyprexa suit.
Plead guilty to criminal conduct for pushing lethal psychiatric drugs on children and elderly.
Pays largest fine in Deptartment of Justice history.

Watch this 3 minute video: Read the rest of this entry »

FDA Panel to Review Zyprexa Side Effects for Children

At a meeting of the FDA’s Pediatric Advisory Committee today, potential label changes will be considered for Eli Lilly’s antipsychotic drug Zyprexa. The Committee will evaluate whether new warnings are necessary about the risk of potential Zyprexa side effects for children, such as severe weight gain, hyperglycemia or other metabolic effects… Read the rest of this entry »

Zyprexa Patient Develops Diabetes – Canadian Class Action Lawsuit

Eli Lilly, manufacturer of Zyprexa and other psych drugs is not just being sued in the U.S., but also in Canada.

Lilly Loses Appeal to Limit Damages in Canadian Suit (Update 2) By Joe Schneider

July 2 (Bloomberg) — Eli Lilly & Co. lost an appeal to limit potential damages in a lawsuit filed by Canadian patients who claimed they developed diabetes after using its Zyprexa schizophrenia drug.

An Ontario appeal court today affirmed a lower court’s decision that plaintiffs in a class-action, or group, suit may try to recover money the Indianapolis-based company made from sales rather than get damages. The plaintiffs sought C$900 million in damages in their initial claim. Read the rest of this entry »

Zyprexa Lawsuit Settlements

Secerecy’s Dangerous Side Effects

By Richard Zitrin
February 08, 2007

DRUG GIANT Eli Lilly & Co. recently settled 18,000 lawsuits brought by people claiming they were injured by the side effects of its biggest-selling drug, Zyprexa, which is used to treat schizophrenia and bipolar disorder. But the $500 million in settlements says less about the dangers of the drug than the dangers of secrecy.

About 18 months earlier, Lilly had settled 8,000 other Zyprexa cases for $700 million. But those settlements required the plaintiffs to return all sensitive documents obtained through the legal discovery process to Lilly – a requirement that kept the strongest smoking-gun evidence out of public view. The plaintiffs also had to agree “not to communicate, publish or cause to be published, in any public or business forum or context, any statement, whether written or oral, concerning the specific events, facts or circumstances giving rise to [their] claims.” Read the rest of this entry »